The National Lung Screening Trial (NLST) reported a reduction in lung cancer mortality in high - risk participants aged 55 to 74 who were randomly assigned to screening with low - dose computed tomography (LDCT) versus chest radiography. (sciencedaily.com)
They estimate that this screening strategy would reduce lung cancer mortality by 9.05 % compared to no screening, with an incremental cost - effectiveness ratio of $ 41,136 Canadian dollars per life - year gained. (sciencedaily.com)
Lung cancer mortality rates among young women (30 - 49 years) were stable or declining in 47 of the 52 populations examined. (sciencedaily.com)